αSyn Therapies
| Friday, April 11, 2025 |
| 12:30 PM - 1:50 PM |
Overview
Moderators: Tiago Fleming Outeiro & Arianna Bellucci
Five minute flash talks
PK7/Syntacasyn: a Synapsin III ligand reducing alpha-synuclein aggregation and exerting significant disease-modifying effects in experimental models of Parkinson’s disease
Francesca Longhena, University of Cambridge
Neuronal-type specific SNCA-targeted epigenome therapy for precision medicine in Synucleinopathies: Preclinical studies
Ornit- Chiba-Falek, Duke University
SNCA-targeting antisense oligonucleotides as a therapeutic approach for alpha-synucleinopathies
Epaminondas Doxakis, Biomedical Research Foundation of the Academy of Athens
Round Table With Industry Leaders
Contributors
Diederik Moechars, Senior Scientific Director at Janssen
Armin Giese, CSO & Founder, MODAG GmbH
Pekka Kallunki, Research Fellow, H. Lundbeck A/s
Pablo Sardi, Global Head, Rare and Neurologic Diseases Therapeutic Area, Sanofi
Simon Stott, Cure Parkinson's
Speaker
Prof. Arianna Bellucci
Associate Professor Of Pharmacology
University of Brescia
αSyn THERAPIES
12:30 PM - 1:50 PM
Prof. Tiago Outeiro
University Medical Center Goettingen
αSyn THERAPIES
12:30 PM - 1:50 PM
Dr. Francesca Longhena
Research Associate
University of Cambridge, Dept. of Clinical Neurosciences
PK7/Syntacasyn: a Synapsin III ligand reducing alpha-synuclein aggregation and exerting significant disease-modifying effects in experimental models of Parkinson’s disease
12:35 PM - 12:40 PM
Professor Ornit Chiba-Falek
Professor of Neurology and Pathology
Division of Translational Brain Sciences, Department of Neurology, and the Center for Genomic and Computational Biology,
Neuronal-type specific SNCA-targeted epigenome therapy for precision medicine in Synucleinopathies: Preclinical studies
12:40 PM - 12:45 PM
Dr Epaminondas Doxakis
Principal Investigator
Biomedical Research Foundation of the Academy of Athens
SNCA-targeting antisense oligonucleotides as a therapeutic approach for alpha-synucleinopathies
12:45 PM - 12:50 PM
Dr. Diederik Moechars
Senior Director
Janssen Pharmaceutical Companies of Johnson and Johnson
ROUND TABLE WITH INDUSTRY LEADERS
12:50 PM - 1:50 PM
Prof. Dr. Armin Giese
CSO & Founder
Modag GmbH
ROUND TABLE WITH INDUSTRY LEADERS
12:50 PM - 1:50 PM
Phd Pekka Kallunki
Research Fellow
H. Lundbeck A/s
ROUND TABLE WITH INDUSTRY LEADERS
12:50 PM - 1:50 PM
Dr S. Pablo Sardi
Sanofi
ROUND TABLE WITH INDUSTRY LEADERS
12:50 PM - 1:50 PM
Dr Simon Stott
Driector of Research
Cure Parkinson’s
ROUND TABLE WITH INDUSTRY LEADERS
12:50 PM - 1:50 PM
